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Asthma is characterized by airway hyperresponsiveness and airway remodeling, which are largely attributed to
increased airway smooth muscle contractility and cell proliferation. It is known that both chemical and mechanical
stimulation regulates smooth muscle contraction. Recent studies suggest that contractile activation and mechanical
stretch induce actin cytoskeletal remodeling in smooth muscle. However, the mechanisms that control actin
cytoskeletal reorganization are not completely elucidated. This review summarizes our current understanding
regarding how actin-associated proteins may regulate remodeling of the actin cytoskeleton in airway smooth
muscle. In particular, there is accumulating evidence to suggest that Abelson tyrosine kinase (Abl) plays a critical
role in regulating airway smooth muscle contraction and cell proliferation in vitro, and airway hyperresponsiveness
and remodeling in vivo. These studies indicate that Abl may be a novel target for the development of new therapy
to treat asthma.
Introduction
Airway smooth muscle cell contraction and proliferation
contribute to the pathogenesis of airway hyperrespon-
siveness (AHR) and airway remodeling [1–8], cardinal
features of asthma that affect nearly 25 million people in
the United Sates and 250 million people worldwide
(www.cdc.gov and www.who.int). However, the cellular
and molecular mechanisms that regulate smooth muscle
cell contraction and proliferation are not fully understood.
Understanding these cellular processes is fundamental to
our knowledge regarding smooth muscle biology and the
pathogenesis of asthma.
Upon external stimulation, myosin light chain under-
goes phosphorylation at Ser-19, which activates myosin
ATPase and initiates sliding of contractile filaments and
smooth muscle contraction [9, 10]. More importantly,
there is a wealth of evidence to suggest that actin cytoskel-
etal remodeling is critical for smooth muscle contraction.
A pool of actin monomers polymerizes onto existing actin
filaments in smooth muscle in response to contractile
stimulation. Inhibition of the G-actin to F-actin transition
by pharmacological tools and molecular approach at-
tenuates smooth muscle contraction without affecting
myosin light chain phosphorylation [11–14]. Actin
filament polymerization may promote smooth muscle
force development by enhancing the transmission of force
between the contractile unit and the extracellular matrix
[11–16]. Smooth muscle contraction is similar to “the
moving of a car”. Myosin may serve as an “engine” for
smooth muscle contraction whereas the actin cytoskeleton
may function as a “transmission system” in smooth
muscle [17, 18].
During breathing, airway smooth muscle is constantly
subjected to mechanical oscillation, which affects airway
smooth muscle contractility. There is evidence that
mechanical stretch induces fluidization and resolidifica-
tion of smooth muscle cells, suggesting actin cytoskeletal
remodeling (actin depolymerization and polymerization)
in the cells upon transient stretch [19]. However, the
mechanisms underlying the dynamic actin cytoskeleton
are not well elucidated.
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The mitogen-activated protein kinase (MAPK) pathway
plays an essential role in regulating various cellular func-
tions including cell proliferation [20–22]. In response to
stimulation with growth factors within minutes, MEK1/2
(MAPK kinase) gets phosphorylated by Raf-1 kinase
[22, 23], which in turn phosphorylates and activates
extracellular signal-regulated kinase1/2 (ERK1/2). Ac-
tivated ERK1/2 phosphorylates several protein kinases,
transcription factors, and other proteins to promote
cell proliferation eventually [20–23]. Recent studies
demonstrate a critical role of actin-regulatory proteins
in the growth factor-associated signaling and prolifer-
ation in smooth muscle cells [20, 21, 24].
This review will summarize our current understanding
of physiological properties of the actin-associated pro-
teins in smooth muscle reactivity and proliferation in
vitro and their roles in the pathogenesis of AHR and air-
way remodeling in vivo. In particular, there is evidence to
suggest that Abelson tyrosine kinase (Abl, c-Abl) plays a
critical role in controlling airway smooth muscle
contraction and cell proliferation in vitro, and AHR and
airway remodeling in vivo. These studies indicate that Abl
may be a novel target for the development of new therapy
to treat asthma.
Role of actin-associated proteins in smooth
muscle contraction
Critical role of actin polymerization in smooth muscle
contraction
Actin filaments of smooth muscle cells attach to dense
plaques containing integrins on the membrane, and
connect with dense bodies in the cytoplasm. The major-
ity of actin (thin) filaments localize around myosin
(thick) filaments in a rosette array, forming the contract-
ile machinery. This pool of actin filaments is referred to
as “contractile actin”. In addition, “cytoskeletal actin”
does not structurally interact with myosin filaments,
which plays a role in maintaining the structural integrity
of smooth muscle cells. The structure of the actin cyto-
skeleton in smooth muscle cells has been described in
detail elsewhere [14, 25, 26].
Actin polymerization and depolymerization occur during
the contraction-relaxation cycle of smooth muscle
There is accumulating evidence to suggest that actin
filament polymerization transpires in smooth muscle
in response to contractile activation, and actin
depolymerization occurs during the relaxation of
smooth muscle. First, we and others have used an actin
fractionation assay and calculated that in unstimulated air-
way smooth muscle cells/tissues, 70–80 % of total actin
exists in insoluble actin (F-actin) whereas 20–30 % of total
actin is found in soluble actin (G-actin). In response to
contractile activation, 85–90 % of total actin is F-actin in
airway smooth muscle cells/tissues [11, 16–18, 27–30]. By
using the fractionation assay, a number of research teams
have found that contractile stimulation increases the
amount of F-actin and/or decreases the G-actin level in
arterial smooth muscle tissues [12, 13, 29–31]. Further-
more, the F-actin/G-actin ratios are reduced in smooth
muscle during relaxation [31–33]. Second, several groups
including our laboratory have also used fluorescent mi-
croscopy to evaluate F-actin and G-actin by reacting
smooth muscle tissues/cells with phalloidin (for F-actin)
and DNase I (for G-actin) conjugated with fluorescent la-
bels [33–36]. Treatment of human airway smooth muscle
cells with carbachol and endothelin-1 leads to the increase
in the ratio of F-actin to G-actin as estimated by fluores-
cence microscopy, whereas treatment with smooth muscle
relaxants (isoproteronol and forskolin) decreases the
F-actin/G-actin ratios [33, 36, 37]. In other studies,
stimulation with vasoconstrictors enhances the F-actin/G-
actin ratios in vascular smooth muscle as evaluated by
fluorescent microscopy [12, 34, 35]. Third, a decrease of
the G-actin pool was observed in contractile airway
smooth muscle tissues by using the DNase inhibition
assay [11, 14]. In addition, Barany et al. also documented a
reduced G-actin content in contractile arterial smooth
muscle by measuring the exchange rates of actin-bound
nucleotide [11, 38]. Taken together, these studies demon-
strate that actin polymerization and depolymerization
occur in various smooth muscle cell/tissue types during
the contraction-relaxation cycle.
Inhibition of actin polymerization attenuates smooth
muscle contraction
The inhibition of actin polymerization by pharmacological
agents such as cytochalasin or latrunculin attenuates the
contraction in a variety of smooth muscle tissues includ-
ing airway smooth muscle [32, 35, 39–41]. Cytochalasin
caps existing actin filaments at the barbed end, preventing
F-actin elongation whereas latrunculin binds to G-actin
and blocks the assembly of G-actin onto actin filaments
[11, 14, 42, 43]. The short-term treatment of smooth
muscle with these inhibitors does not impair the
organization and ultrastructure of contractile filaments
[11, 14]. Furthermore, inhibition of actin polymerization
by molecular approaches that interfere with actin-
regulatory proteins also attenuates smooth muscle
contraction [16–18, 30, 35, 44–48]. More importantly, the
suppression of actin polymerization inhibits force devel-
opment in smooth muscle with little or no effects on
myosin light chain phosphorylation, a cellular event that is
essential for smooth muscle contraction [16–18, 30, 35,
44–48]. Therefore, these results suggest that actin filament
polymerization and myosin activation are two parallel cel-
lular processes that are fundamental for the regulation of
smooth muscle contraction.
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How does actin polymerization affect the contraction in
smooth muscle? First, the actin filaments of smooth
muscle cells connect to the cytoplasmic domain of β integ-
rins via linker proteins such as vinculin, talin and α-actinin
whereas the extracellular portion of β integrins engages
with the extracellular matrix [11, 14, 15, 25, 26, 49, 50].
Thus, the actin-integrin-matrix connection provides the
structural basis for the force transmission between the
contractile unit and the extracellular matrix [11, 14, 15, 25,
26, 49–53]. Nascent actin polymerization may occur at the
cell cortex of smooth muscle [11, 14, 15, 25, 27, 28, 49, 54].
Cortical actin assembly may strengthen the linkage of actin
filaments to integrins and enhance the transmission of
contractile force [11, 14, 15, 25, 30, 35, 44, 53, 55].
Second, actin filament assembly may participate in the
“latch” formation of contractile filaments, supporting force
maintenance under the condition of lower crossbridge
phosphorylation [13, 14, 56, 57]. Third, our recent studies
suggest that actin polymerization promotes the recruit-
ment of β-catenin to N-cadherin (critical components of
intercellular junctions), which may facilitate the cell-to-
cell force transmission and contraction [58].
Regulation of actin dynamics in smooth muscle
In the last decade, a wealth of information has been accu-
mulated to elucidate how actin filament polymerization/
depolymeration is regulated in smooth muscle. Thus far,
protein kinases, such as Abl, p21-activated kinase (PAK),
focal adhesion kinase (FAK), integrin-linked kinase (ILK)
and other kinases, have been reported to regulate actin
polymerization in smooth muscle. Transmembrane integ-
rins may be able to activate signaling pathways coordinat-
ing actin dynamics in smooth muscle. Rho, Cdc42, and
Rac are the major members of Rho family of the small
GTPases that mediates actin polymerization in smooth
muscle. The actin-regulatory proteins are effectors in the
signaling cascades to mediate actin dynamics. Some of the
proteins are neuronal Wiskott-Aldrich syndrome Protein
(N-WASP), the Arp2/3 complex, cortactin, glia matur-
ation factor-γ (GMF-γ), Abl interactor 1 (Abi1), profilin,
cofilin, and heat shock proteins. Generally speaking, re-
ceptor activation and/or integrin ligation activates protein
kinases and/or small GTPases, which subsequently regu-
late the functional status of the actin regulatory proteins
and eventually actin filament assembly or structural
reorganization. However, these protein interactions and
signaling pathways are complex and may be cell-type and
species dependent. The expression and role of actin-
associated proteins in different cell types and species are
summarized in Table 1.
Role of Abl tyrosine kinase in smooth muscle
Abl is a non-receptor protein tyrosine kinase that is ubi-
quitously expressed and has been implicated to function
in a variety of cellular processes including the regulation
of the actin cytoskeleton that mediates cell migration
and adhesion [59–61]. There is evidence that Abl
tyrosine kinase is necessary for airway smooth muscle
contraction. Smooth muscle cell–specific knockout of
Abl attenuates contractile responses of mouse tracheal
rings to acetylcholine (ACh) [5]. Moreover, acute treat-
ment with the Abl pharmacological inhibitors imatinib
(Gleevec, STI-571) [5, 47, 62] and GNF-5 [63] signifi-
cantly inhibits force development in mouse tracheal
rings induced by ACh. Furthermore, treatment with ima-
tinib or GNF-5 induces the relaxation of tracheal rings
precontracted by ACh [5]. In addition, treatment with
imatinib attenuates airway smooth muscle reactivity in
vivo [64].
Abl has also been shown to regulate vascular smooth
muscle contraction. Knockdown of Abl inhibits force
development in arterial smooth muscle tissues during
contractile activation [48]. Moreover, treatment with a
cell permeable peptide or imatinib attenuates vascular
smooth muscle contraction [47]. Interestingly, adminis-
tration of the Abl inhibitor imatinib lessens the clinical
symptoms of patients with pulmonary arterial hyperten-
sion [65, 66], suggesting a role for Abl in pulmonary
arterial contraction.
How does Abl regulate force development in smooth
muscle? To answer the question, the effects of Abl
knockdown or inhibition on actin dynamics and myosin
phosphorylation was evaluated. Knockdown of Abl atten-
uates actin polymerization in smooth muscle cells/tissues
during contractile stimulation [14, 17, 48]. Inhibition of
Abl activation by a cell permeable peptide also diminishes
actin dynamics in smooth muscle stimulated by contract-
ile agonists [47]. However, silencing or inhibition of Abl
does not affect myosin light chain phosphorylation in
smooth muscle [47, 48]. These observations suggest that
Abl regulate smooth muscle contraction by controlling
actin polymerization, but not myosin activation during
contractile stimulation [11, 12, 16–18, 35, 45].
Contractile stimulation induces phosphorylation of Abl
tyrosine kinase at Tyr-412 in smooth muscle [47, 48]. Tyr-
412 is located at the activation loop of Abl kinase domain.
When unstimulated, the activation loop of the Abl kinase
domain folds into the active site, thereby preventing bind-
ing of both the substrate and ATP. Phosphorylation at
Tyr-412 induces conformation changes; the activation
loop no longer blocks the active site, which leads the in-
crease in kinase activity [14, 47, 48, 60]. Abl tyrosine phos-
phorylation is regulated by Src in smooth muscle cells/
tissues in response to contractile activation [15, 48, 67].
Similarly, Abl phosphorylation is also mediated by Src in
fibroblasts [68] and cancer cells [69].
Abl regulates actin dynamics in smooth muscle by con-
trolling several downstream effectors. Abi1 is an adapter
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protein that has been implicated in the regulation of
actin dynamics in vitro [70], cell adhesion and migration
[71, 72]. In human airway smooth muscle cells/tissues,
contractile stimulation induces an increase in the as-
sociation of Abi1 with N-WASP (an actin nucleation
activator) [17]. N-WASP is known to regulate the
Arp2/3-mediated actin polymerization and branching
[55, 73, 74]. Furthermore, contractile stimulation acti-
vates N-WASP in live smooth muscle cells as evidenced
by changes in fluorescence resonance energy transfer
efficiency of an N-WASP sensor [17]. Abi1 is necessary
for N-WASP activation, actin polymerization and the
contraction in smooth muscle. However, Abi1 does not
affect myosin light chain phosphorylation [17]. More im-
portantly, contractile activation induces the formation of a
multiprotein complex including Abl, Crk-associated sub-
strate (CAS) and Abi1. CAS is an adapter protein that
participates in the regulation of smooth muscle tension
development [15, 32, 39, 67]. Knockdown of Abl and CAS
attenuates the activation of Abi1 during contractile activa-
tion. Collectively, the results indicate that Abl tyrosine
kinase is able to regulate the formation of the CAS/Abi1/
N-WASP complex, which subsequently activates N-
WASP and actin polymerization [15, 17, 32, 39] (Fig. 1).
Cortactin is an actin-regulatory protein that is able to
regulate actin filament assembly in in vitro studies as
well as adhesion, migration, endocytosis of nonmuscle
cells [75, 76]. In human airway smooth muscle cells/tis-
sues, cortactin controls actin polymerization and force
development without affecting myosin activation [18].
Furthermore, contractile stimulation induces cortactin
phosphorylation at Tyr-421 and the association of cor-
tactin with profilin-1 (Pfn-1) that is able to transport
actin monomers onto actin filaments [18, 32, 39]. The
Table 1 The expression and role of actin-associated proteins in different cell-types and species
Name Cell types Species Role References
Abi1 ASMCs, VSMCs Human Adapter protein [17]
Abl ASMCs, VSMCs Human, rat, mouse Tyrosine kinase [5, 17, 47, 48]
Arp2/3 ASMCs, VSMCs Human, rat, canine Promote actin branching [17, 48, 54]
CAS ASMCs, VSMCs Human, rat Adapter protein [17, 48]
Cdc42 ASMCs Canine Small GTPase [11, 27, 28]
Cofilin ASMCs Canine Actin regulator [45]
Cortactin ASMCs Human Adapter protein [18, 125]
CrkII ASMCs Canine Adapter protein [27]
FAK ASMCs Canine Tyrosine kinase [87, 88]
GMF-γ ASMCs Human Promote actin debranching [16]
HDAC8 ASMCs Human, mouse Histone deacetylase [111]
HSP27 ASMCs Canine Heat shock protein [53]
ILK ASMCs Canine Adapter protein, kinase [11, 55]
Integrin-β1 ASMCs Human, canine Link ECM to actin cytoskeleton [52, 55]
N-Cadherin ASMCs Human Adherens junction protein [58]
N-WASP ASMCs, VSMCs Human, rat, canine Promote actin nucleation [17, 48, 55]
p38MAPK ASMCs Canine Serine/threonine kinase [93]
PAK1 ASMCs Canine, mouse, human Serine/threonine kinase [80, 93, 131]
Parvin ASMCs Canine Actin binding protein [55]
Paxillin ASMCs Canine Adapter protein [55, 82, 83]
PINCH ASMCs Canine ILK binding partner [11, 55]
Profilin ASMCs, VSMCs Human, canine Promote actin transport [18, 32]
RhoA ASMCs Canine, human Small GTPase [30, 104]
Talin ASMCs Canine Structural protein [29, 51]
VASP ASMCs Canine Phosphoprotein [44]
Vinculin ASMCs Canine Structural protein [29, 51]
α-Actinin ASMCs Canine Cross linking protein [52]
β-Catenin ASMCs Human Adherens junction protein [58]
ASMCs airway smooth muscle cells, VASMCs vascular smooth muscle cells
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cortactin/Pfn-1 complex is also rapidly recruited to the
membrane upon contractile activation. The disruption of
the protein-protein interaction by a cell permeable pep-
tide attenuates actin polymerization and smooth muscle
contraction. More importantly, Abl has a critical role in
regulating the agonist-induced cortactin phosphorylation
and the interaction of cortactin with Pfn-1 [18]. These
results suggest that cortactin phosphorylation and cor-
tactin/Pfn-1 coupling play a pivotal role in regulating
actin dynamics and smooth muscle contraction. Abl
regulates the association of cortactin with Pfn-1 and
actin polymerization by catalyzing cortactin phosphoryl-
ation (Fig. 1).
GMF-γ is a member of actin-depolymerizing factor
(ADF)/cofilin family that is widely expressed in eukary-
otes and plays a central role in reorganizing the actin
cytoskeleton by inducing actin network debranching
[77, 78]. GMF-γ is able to inhibit actin nucleation in
vitro [78]. Moreover, in vitro biochemical studies show
that GMF-γ may induce debranching of the actin filament
networks [77, 78]. Knockdown of GMF-γ enhances actin
polymerization and the contraction in human airway
smooth muscle cells/tissues with little or no effect on my-
osin phosphorylation [16]. Contractile activation induces
GMF-γ phosphorylation at Tyr-104 and dissociation of
GMF-γ from Arp2 of the Arp2/3 complex, which is regu-
lated by Abl tyrosine kinase. Furthermore, expression of
mutant Y104F GMF-γ attenuates actin polymerization
and contraction in smooth muscle [16]. Thus, Abl tyrosine
kinase is able to phosphorylate GMF-γ at Tyr-104, which
inhibits the ability of GMF-γ to induce actin network
disassembly (Fig. 1).
Role of the integrin-associated complex in actin
polymerization
Transmembrane integrins are localized in membrane-
associated dense plaques (similar to focal adhesion sites of
cultured cells) and connect the extracellular matrix with
the actin cytoskeleton in smooth muscle [11, 14, 15]. In
addition, a number of structural and signaling proteins are
found in the integrin-associated structure (Fig. 2). During
cell migration, the engagement of integrins with the extra-
cellular matrix initiates the recruitment of actin-associated
proteins to the membrane, which eventually promotes
actin polymerization [11, 61, 79]. There is evidence to
suggest that contractile stimulation induces the assembly
of the multiprotein complex at the membrane, which is
critical for the regulation of actin polymerization in
smooth muscle [30, 35, 44, 45, 47, 55, 80, 81].
In canine tracheal smooth muscle, a stable protein
complex containing ILK (a β-integrin binding scaf-
folding protein and protein kinase), PINCH (an ILK
binding partners) and α-parvin (an actin-binding pro-
tein) is recruited to integrin adhesion sites in re-
sponse to contractile stimulation, where it interacts
with β-integrins and forms a platform for the recruit-














Fig. 1 Mechanisms of Abl-regulated actin polymerization. Stimulation with agonists such as acetylcholine may activate Abl tyrosine kinase, which
regulates the formation of the multiprotein complex including Crk-associated substrate (CAS), the adapter protein Abi1 (Abl interactor 1)
and N-WASP (neuronal Wiskott-Aldrich Syndrome Protein), which in turn activates N-WASP, actin polymerization and smooth muscle contraction.
Activated Abl also catalyzes phosphorylation of GMF-γ (glia maturation factor-γ) at Tyr-104, which induces the dissociation of GMF-γ from Arp2/3, and
promotes actin polymerization. Furthermore, contractile agonists promote the association of cortactin (CTTN) with profilin-1 (Pfn-1), which induces
actin polymerization and smooth muscle contraction. The interaction of cortactin with Pfn-1 is regulated by cortactin phosphorylation and Abl
tyrosine kinase
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are required for the processes of actin cytoskeletal re-
modeling and mechanotransduction [11, 55].
Paxillin, a scaffolding and signaling protein, is required
for tracheal smooth muscle contraction [82, 83] and is
also recruited to membrane adhesion sites in response
to contractile stimulation, where it associates with the
ILK-associated complex [55]. Paxillin has been shown to
undergo tyrosine phosphorylation in response to con-
tractile stimulation in many smooth muscle cell and
tissue types [13, 84–86]. The tyrosine phosphorylation of
paxillin at Tyr-31 and −118 promotes its interaction
with the SH2/SH3 adaptor protein CrkII, which binds to
N-WASP and contributes to N-WASP and Arp2/3
activation [27]. Paxillin phosphorylation is mediated by
FAK in smooth muscle [87, 88].
Integrin activation may also stimulate FAK and paxillin
in smooth muscle; the tyrosine phosphorylation of FAK
and paxillin is mechanosensitive (integrin is a known
mechanosensor) in smooth muscle [86, 88].
in smooth muscle [86, 88]. Cyclic strain promotes
Pyk2 and FAK phosphorylation at focal adhesion sites in
cells. The integrin-mediated activation of tyrosine kinases
in turn modulates the functional status of downstream
molecules such as paxillin and Hic-5 that are related to
remodeling of the actin architecture [14].
Contractile stimulation also induces the recruitment of
structural proteins that participate in the linkage of actin
filaments to β-integrin in adhesion sites, which may
strengthen the connection of actin filaments with the
membrane. The cytoskeletal protein vinculin is recruited
to the ILK-associated complex at adhesion sites [55].
Vinculin binds to talin via its head domain and to actin
filaments via its tail domain. Contractile activation induces
vinculin phosphorylation, which promotes the binding of
vinculin to talin and actin filaments and tension develop-
ment [29, 51].
α-Actinin is an actin cross-linking protein that also
binds to integrin proteins. Stimulation with a con-
tractile agonist induces rapidly the recruitment of α-
actinin to the integrin-associated complexes of canine
tracheal smooth muscle cells/tissues [52]. In the
tracheal tissues, the recruitment of α-actinin is
required for smooth muscle contraction but not for
actin polymerization or myosin activation [52]. These
observations demonstrate that disruption of the




































Fig. 2 Molecular interactions of scaffolding/signaling proteins at or near intergrin-associated junctions. Cytoplasmic tails of integrins connect with
actin filaments via actin linker proteins such as talin, vinculin, paxillin and α-actinin. The extracellular domains of integrins interact with the extracellular
matrix, forming the integrin-associated junctions. Signaling and scaffolding proteins are assembled at or near the integrin-associated junctions upon
contractile activation, which facilitates actin polymerization and the mechanotransduction between the contractile unit and the extracellular matrix.
Abi1, Abl interactor 1; Abl, Abelson tyrosine kinase; CAS, Crk-associated substrates; CTTN, cortactin; FAK, focal adhesion kinase; GMF-γ, glia maturation
factor-γ; HDAC8, histone deacetylase 8; HSP, heat shock protein; ILK, integrin-linked kinase; MAPK, mitogen-activated protein kinase; MK2,
MAP kinase-activated protein (MAPKAP) kinase 2; N-WASP, neuronal Wiskott-Aldrich Syndrome Protein; PAK, p21-activated kinase; Pfn-1,
profilin-1; VASP, vasodilator stimulated phosphoprotein
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adhesions is sufficient to inhibit smooth muscle con-
traction [11, 14, 35] (Fig. 2).
Small GTPases and PAK in smooth muscle
Rho, Cdc42, and Rac are the members of the small
GTPase Rho family. There is ample evidence that Cdc42
regulates actin polymerization in various cell types
including smooth muscle cells [27, 28, 30, 89–92].
Activated Cdc42 binds to the GTP binding domain of
N-WASP, inducing a conformational change and acti-
vating N-WASP, and triggering the nucleation of actin
polymerization and actin filament branching [11, 27,
28, 73, 74]. In canine tracheal smooth muscle tissues,
introduction of a dominant Cdc42 mutant depresses
the activity of N-WASP concurrently with the de-
crease in actin polymerization and force development
[11, 27, 28], suggesting that Cdc42-mediated actin
assembly is essential for smooth muscle contraction.
Cdc42 and Rac are known to activate PAKs in mam-
malian cells [80, 93–96]. Although 6 isoforms have been
found thus far, PAK1 is a major isoform in smooth
muscle cells [80, 91–93, 95–98]. PAK has been shown to
participate in the regulation of p38 MAP kinase in
smooth muscle upon external activation [53, 93]. The
activation of p38 MAP kinase may modulate the actin
cytoskeleton and cell migration via heat shock protein
27 (HSP27) [14, 15, 53, 93]. In vitro biochemical studies
have shown that unphosphorylated HSP25 (mouse and
chicken homologs of HSP27) inhibits actin polymerization
whereas phosphorylated HSP27 loses the ability to inhibit
actin filament assembly [53, 94, 99, 100]. p38 MAP
kinase may phosphorylate MAP kinase-activated pro-
tein (MAPKAP) kinase 2 (MK2), which subsequently
catalyzes HSP27 phosphorylation and promotes actin
polymerization and contraction [14, 53, 101] (Fig. 2).
PAK1 also regulates smooth muscle contraction by
controlling the vimentin intermediate filament network
[80, 91, 92, 94, 95, 97, 102]. Vimentin network undergoes
phosphorylation at Ser-56 and spatial reorganization in
smooth muscle cells/tissues in response to contractile
stimulation, which is critical for smooth muscle force de-
velopment [80, 95, 97, 102]. PAK1 deficiency reduces
vimentin phosphorylation, reorientation of the vimentin
network and smooth muscle contraction. Moreover,
PAK1 is able to catalyze vimentin phosphorylation in
vitro [80, 91, 92, 94, 95, 97, 102, 103]. Thus, PAK1
regulates smooth muscle force development in part
by modulating vimentin phosphorylation and reorien-
tation of the vimentin network.
Rho activation promotes actin stress fiber formation in
cultured smooth muscle cells [104, 105], and actin
polymerization in smooth muscle tissues during contract-
ile stimulation [30]. In canine tracheal smooth muscle,
contractile stimulation activates RhoA, which induces the
independent recruitment of paxillin-vinculin complexes
and FAK to cell adhesomes. Activated FAK induces the
phosphorylation of paxillin, which remains bound to acti-
vated vinculin. Paxillin phosphorylation also facilitates the
formation of a complex containing paxillin and Crk II
with DOCK180 and PIX GEFs. This complex induces the
activation of Cdc42, which in turn promotes the activation
of N-WASP, which interacts with the Arp2/3 complex to
induce actin polymerization in the cortical region of the
smooth muscle cell [30] (Fig. 2).
Regulation of actin polymerization by histone deacetylase 8
Histone deacetylases (HDACs) are a family of enzymes
that are originally identified as key regulators of histone
deacetylation, nucleosome stability and gene transcrip-
tion [106, 107]. The HDAC family members have long
been thought to regulate nucleosomal histone acetyl-
ation solely. HDACs typically induce histone deacety-
lation and repress gene transcription [108]. However,
recent studies suggest that some HDACs are present
in the cytoplasm of nonmuscle cells, which has been
implicated in regulating cell migration and micro-
tubule dynamics [109, 110].
HDAC8 is localized both in the cytoplasm and the
nucleus of mouse and human airway smooth muscle
cells. HDAC8 is required for the contraction of smooth
muscle tissues [111] and cultured smooth muscle cells
[112]. In addition, cortactin is an actin-regulatory protein
that undergoes deacetylation during migration of NIH
3 T3 cells [110]. Contractile stimulation induces cortactin
deacetylation in mouse and human smooth muscle tissues.
Knockdown or pharmacological inhibition of HDAC8 at-
tenuates cortactin deacetylation, actin polymerization and
contraction without affecting myosin activation. Fur-
thermore, expression of a charge-neutralizing cortac-
tin mutant inhibits contraction and actin dynamics
during agonist activation [111]. Taken together, these
results suggest a novel paradigm for the regulation of
actin dynamics in smooth muscle: Upon contractile
activation, HDAC8 induces cortactin deacetylation,
which in turn promotes actin polymerization and the
contraction in airway smooth muscle (Fig. 2).
Regulation by cofilin/ADF and vasodilator stimulated
phosphoprotein (VASP)
Cofilin/ADF are members of a family of “actin-dynamiz-
ing proteins,” which are able to regulate the availability
of actin monomers for actin filament assembly [11].
Cofilin binds to F-actin, severs actin filaments and pro-
vides more free barbed ends of actin filaments for nas-
cent actin polymerization. Cofilin activity is regulated by
its phosphorylation at Ser-3, which abolishes the ability
of cofilin to bind to F-actin and thus inhibits its severing
function [11, 45, 113].
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In canine tracheal smooth muscle, contractile activa-
tion decreases cofilin phosphorylation at Ser-3, which is
associated with force development [45]. Expression of an
inactive phospho-cofilin mimetic (cofilin S3E) in the
smooth muscle tissues inhibits endogenous ADF/cofilin
dephosphorylation and actin polymerization. Expression
of cofilin S3E in the tissues depresses tension develop-
ment in response to ACh, but it does not influence myosin
light chain phosphorylation. These observations verify the
role of cofilin in regulating the availability of actin mono-
mers for actin polymerization in smooth muscle [11, 45].
In addition, cofilin phosphorylation at Ser-3 is regulated
by protein phosphatase 2B [11, 45].
Members of the Ena/VASP protein family can promote
actin polymerization by elongating actin filaments. The
elongation mechanism involves VASP oligomerization
and its binding to profilin and vinculin. In tracheal smooth
muscle, treatment with ACh or forskolin (an adenylyl cy-
clase activator) increases VASP Ser-157 phosphorylation
[44]. VASP undergoes phosphorylation at Ser-157 in a bi-
phasic manner in aortic smooth muscle during stimula-
tion with phenylephrine [35]. Treatment with ACh but
not forskolin triggers the formation of VASP-VASP com-
plexes as well as VASP-vinculin and VASP-profilin com-
plexes at membrane sites. VASP-VASP complex formation
and the interaction of VASP with vinculin and profilin are
inhibited by an inactive vinculin mutant, but VASP phos-
phorylation and membrane localization are unaffected
[44]. Gunst et al. conclude that VASP phosphorylation at
Ser-157 mediates its localization at the membrane, but
Ser-157 phosphorylation and membrane localization are
not sufficient to activate its actin polymerization activity
(as in the forskolin case). The interaction of VASP with
activated vinculin at membrane sites is essential for
VASP-mediated actin polymerization (Fig. 2) [44].
Adherens junctions and smooth muscle contraction
Adherens junctions are protein complexes that exist at
cell–cell junctions in various cell types including epithe-
lial cells, endothelial cells and muscle cells, which plays
an essential role in intercellular connection and mechan-
otransduction [58, 114–116]. β-Catenin, a member of
the armadillo family of proteins, is a key component of
the cadherin-catenin complex in the plasma membrane
[114]. β-Catenin is composed of an N-terminal head, an
Arm (armadillo) domain and a C-terminal tail. The Arm
domain of β-catenin binds to the cytoplasmic domain of
cadherins; the extracellular domain of cadherins inter-
acts with their counterparts of adjacent cells to form
cell-cell contacts. The N-terminus of β-catenin interacts
with actin filaments via the linker proteins such as α-
catenin, vinculin and VASP [115, 117].
The cadherin-catenin complex is a mechanosensive
and responsive structure [118]. The adherens junctions
undergo reorganization in endothelial cells in response
to tugging forces and thrombin treatment [118]. In
keratinocytes, the engagement of the adherens junc-
tions occurs upon chemical stimulation; the knockout
of β-catenin disrupts the structural change [119]. The
dynamic change of the adherens junctions may allow
cells to adapt their mechanical property and intracel-
lular signaling [118, 119].
β-cateninis a necessary component of the cellular
process that regulates smooth muscle contraction
[58, 120]. However, β-catenin is not involved in the
regulation of actin polymerization, myosin activation or
contractile protein expression [58, 120]. Contractile stimu-
lation promotes the recruitment of β-catenin to N-
cadherin in human airway smooth muscle cells/tissues.
This recruitment of β-catenin to N-cadherin is critical for
smooth muscle contraction. Disruption of the protein-
protein interaction by a β-catenin mutant attenuates
smooth muscle force development [58]. More import-
antly, actin polymerization has a positive role in regulating
the recruitment of β-catenin to N-cadherin. Together,
these findings reveal a novel role of adherens junctions in
smooth muscle contraction: Contractile stimulation
promotes actin polymerization, which may increase
the coupling of β-catenin with N-cadherin and facili-
tate intercellular mechanotransduction (Fig. 3).
Role of actin-associated proteins in smooth muscle
cell proliferation
Cell adhesion, spreading and migration are recognized
as important cellular processes that control cell prolifer-
ation. Disruption of these processes ultimately impairs
the proliferation in various cell types including smooth
muscle cells [20, 21, 61, 121–125]. Actin-regulatory
proteins are known to regulate these cellular func-
tions [61, 93, 126]. Thus, actin-associated proteins are
capable of regulating cell proliferation by controlling cell
adhesion, spreading and movement. In this section of the
review, I will focus on the roles of Abl and PAK1 in
growth factor-mediated signaling and cytokinesis.
Regulation of smooth muscle cell proliferation by
Abl tyrosine kinase
Abl is activated in smooth muscle cells upon stimula-
tion with platelet-derived growth factor (PDGF) and
endothelin-1 [20, 21]. Endothilin-1 receptor is a member
of G protein-coupled receptor (GPCR) family whereas
PDGF receptor belongs to the family of tyrosine kinase-
containing receptors. Both GPCR and tyrosine kinase re-
ceptors play an important role in the regulation of smooth
muscle cell functions [22, 127]. In rat vascular smooth
muscle cells, activation of GPCR by agonists induces
phosphorylation of Src at Tyr-416, which in turn triggers
the activation of Abl [21, 47, 67]. Similarly, cellular
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challenge with PDGF is able to activate Src, which subse-
quently mediates phosphorylation of Abl in mammalian
cells [21, 128].
Abl is necessary for the proliferation in smooth muscle
cells in response to activation with growth factors [20, 21].
Upon the binding of ligands to growth factor receptors,
Raf-1 kinase is translocated to the plasma membrane,
which subsequently activates Raf-1. Activated Raf-1 phos-
phorylates MEK1/2 (MAPK kinase), which in turn phos-
phorylates and activates ERK1/2 and promotes cell
proliferation [22, 23]. In human airway smooth muscle
cells, PDGF activation induces an increase in the associ-
ation of Raf-1 with cytoskeletal actin. Inhibition of actin
polymerization by Abl knockdown or latrunculin A
attenuates the interaction of Raf-1 with F-actin and Raf-1
redistribution during PDGF stimulation. Furthermore, Abl
knockdown inhibits the PDGF-induced MEK and ERK1/2
phosphorylation and the proliferation in human airway
smooth muscle cells (Fig. 4) [20, 21]. However, Abl does
not affect AKT activation in smooth muscle cells upon
growth factor stimulation [20, 21]. Abl regulation of
ERK1/2 phosphorylation has also been reported in non-
muscle cells (e.g., fibroblasts); Abl appears to regulate
SHP-2 tyrosine phosphatase, which subsequently modu-
lates ERK1/2 activation in fibroblasts [129].
Abl also regulates smooth muscle cell proliferation by
controlling cytokinesis, a critical step of cell division
[125]. Abl is localized in the contractile ring of human
airway smooth muscle cells. Knockdown or inhibition of















Fig. 3 Novel mechanism for regulation of adherens junctions in smooth muscle. In addition to myosin activation, contractile agonists induce
actin polymerization, which promotes the recruitment of β-catenin to N-cadherin. The increase in the protein-protein interaction may enhance
the linkage of actin filaments to the adherens junctions, and promote the intercellular force transmission and smooth muscle contraction.









Fig. 4 Regulation of MAPK pathway and cytokinesis by Abl. Upon the
binding of ligands to growth factor receptors, Abl promotes Raf-1
activation by controlling actin dynamics, which in turn modulates
the activation of MEK and ERK. In addition, Abl is recruited to the
midzone during cytokinesis, which mediates cortactin phosphorylation.
Phosphorylated cortactin promotes F-actin assembly, which facilitates
contractile ring formation and cytokinesis
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Cortactin is a tyrosine-phosphorylated protein that has
been implicated in the regulation of actin filament assem-
bly [75, 76]. Phosphorylated cortactin is also found in the
contractile ring. Abl knockdown or inhibition attenuates
cortactin phosphorylation in the midzone and contractile
ring formation. Furthermore, the expression of a nonpho-
sphorylatable cortactin mutant diminishes cytokinesis.
Thus, these results uncover a novel mechanism: Abl is re-
cruited to the equator during cytokinesis, which mediates
cortactin phosphorylation. Phosphorylated cortactin pro-
motes actin filament assembly, which facilitates contractile
ring formation and cytokinesis (Fig. 4) [125].
Role of PAK1 in growth factor-mediated signaling
PAK1 is phosphorylated and activated in rat aortic
smooth muscle cells upon stimulation with growth factors
and angiotensin II [130, 131]. Furthermore, PAK1 activity
is necessary for rat aortic smooth muscle cell proliferation
[24]. In addition, PAK1 is required for mitotic progress in
nonmuscle cells [132].
PAK1 is likely to regulate smooth muscle cell prolifera-
tion by modulating ERK1/2 activation [133–135]. In re-
sponse to cell adhesion to fibronectin, PAK mediates
MEK1/2 phosphorylation at Ser-298, which subsequently
promotes phosphorylation of Ser-218/Ser-222 and acti-
vates MEK1/2 [135]. Similarly, PAK1 is able to regulate
ERK1/2 activation during migration of macrophage [133].
However, these studies have been performed in vascular
smooth muscle cells or nonmuscle cells. Future studies
are required to evaluate whether PAK1 has similar or
distinctive role in airway smooth muscle cell proliferation.
Role of cytoskeleton-regulatory proteins in AHR
and airway remodeling
Critical role of Abl in AHR and airway remodeling in vivo
Asthma is characterized by AHR and airway remodeling,
which are largely due to increased airway smooth muscle
contractility [1–5] and cell proliferation [7, 8]. As de-
scribed earlier, the function of Abl in smooth muscle
contraction and cell proliferation in vitro has been docu-
mented. Until recently, the role of Abl tyrosine kinase in
the pathogenesis of AHR and airway remodeling has
been elusive. In a recent study [5], the expression of Abl
is upregulated in airway smooth muscle tissues of an
animal model of asthma and in asthmatic human airway
smooth muscle cells. Conditional knockout of Abl in
smooth muscle attenuates the methacholine-induced air-
way reactivity in animals sensitized and challenged with
ovalbumin. Intranasal instillation with the Abl inhibitors
imatinib and GNF-5 also inhibits airway resistance in
the diseased animals. These results are supported by a
previous study by others [64]. Furthermore, conditional
knockout of Abl or treatment with the Abl inhibitors
suppresses the agonist-induced airway smooth muscle
hyperreactivity in vitro. The allergen-induced smooth
muscle mass and cell proliferation are also reduced in
the airways of Abl knockout mice or the inhibitor-
treated mice exposed to the allergen [5]. Taken in sum,
these findings demonstrate a pivotal role of Abl in the
allgern-induced AHR and airway remodeling in vivo.
In response to allergic sensitization and challenge, in-
flammatory cells enter into the lungs and cytokine/che-
mokine levels are increased in the bronchoalveolar space
of asthmatic patients and animal models [4, 136, 137].
Because airway smooth muscle cells have ability to se-
crete cytokines in vitro [138], the effects of Abl knockout
in smooth muscle on airway inflammation was also eval-
uated. Conditional knockout of Abl does not affect the
increase in inflammatory cell numbers, IL-13 and CCL2
in animals sensitized and challenged by the allergen. On
the contrary, treatment with imatinib and GNF-5 re-
duces the allergen-induced increase in inflammatory cell
numbers, and levels of IL-13 and CCL2 [5]. The results
suggest that global inhibition of Abl diminishes airway
inflammation in chronic asthma, which is consistent
with the findings that Abl may regulate migration and
synthetic functions of immune cells in vitro [139–142].
There is a need to identify new biological target for
the development of new therapy to treat asthma. As
mentioned above, preclinical studies suggest that Abl
has a critical role in the pathogenesis of AHR, airway re-
modeling and inflammation [5, 64]. In addition, clinical
studies suggest that the Abl inhibitor imatinib is effective
to lessen the clinical symptoms of patients with pulmon-
ary arterial hypertension [65, 66], a disease that is also
involved in abnormal smooth muscle cell contraction
and proliferation. Thus, these findings support the con-
cept that Abl may be a novel target for the development
of new therapy to treat asthma.
Role of PAK1 in AHR in vivo
The potential role of PAK1 in the development of AHR
was described in a recent study [6]. Tepper et al. demon-
strate that inhibiting the activity of p21-activated protein
kinase is an effective approach for reducing AHR in vivo.
PAK1 knockout mice display significantly lower airway
resistance in vivo, and the aerosol administration of a
synthetic small molecule PAK inhibitor also reduces
AHR in mice. Furthermore, isolated tracheal segments
from PAK1−/− mice exhibit reduced contractile response
in vitro, indicating that the decrease in airway reactivity
observed in vivo in PAK1−/− mice results from decreased
airway smooth muscle contraction [6].
However, they did not detect differences in the struc-
ture of the airways and lung parenchyma in PAK1−/−
and wild type animals [6]. Decreased airway responsive-
ness does not appear to result from other factors that
can alter airway responsiveness. These observations
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provide evidence that the reduction of PAK activity
inhibits airway resistance in vivo and that this effect is
caused by a reduction in the contractility of the airway
smooth muscle. Furthermore, PAK inhibition is also able
to attenuate the contraction in human bronchial tissues,
which suggests that this approach could be effective in
humans in vivo also.
Conclusions and perspectives
Exploring the functions and regulation of actin-associated
proteins in smooth muscle is a new trend in smooth
muscle physiology and asthma research. There is a wealth
of evidence that actin polymerization is a key cellular
process that controls smooth muscle contraction. Abl
tyrosine kinase regulates actin cytoskeletal remodeling by
controlling several downstream effectors including Abi1,
cortactin and GMF-γ. Abl also has a role in regulating
smooth muscle cell proliferation. Investigating potential
roles of Abl in other smooth muscle functions is an
interesting topic. There is emerging evidence that actin
polymerization is modulated by protein deacetylation and
that actin polymerization affects adherens junctions and
cell-to-cell mechanotransduction. Understanding how
protein acetylation/deacetylation and adherens junction
assembly are regulated will be important directions in this
research area. Abl and PAK1 are involved in the
pathogenesis of asthma, suggesting that they are potential
biotargets for the development of new treatment of
asthma. Elegant technologies have been employed to
unveil the roles of the integrin-associated complex and
other actin-regulatory proteins in smooth muscle. How-
ever, there is not much information on whether these
complex interactions are involved in asthma pathology.
Filling this knowledge gap will enhance our understanding
of asthma pathology.
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